Delivery Order SPE2DB22D1002-SPE2DB25FLHK6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $35,121.23 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) under a firm fixed-price contract valued at $4,107.42. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 40 mg capsules (30-count packages) valued at $2,332.80, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30 count) with a ceiling value of $1,835.95, effective August 19, 2025, with ultimate completion by August 20, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $10,388.40 delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (10-count units) with a completion date of July 30, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $20,726.74 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. Isotretinoin...
- The Defense Logistics Agency awarded a $2,522.91 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Isotretinoin 30 mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract value of $2,590.48. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,396.64 to Amerisourcebergen Drug Corporation for the provision of 4561772900 isotretinoin 30 mg capsules. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 10 units of the specified pharmaceutical to a location in Conshohocken, Pennsylvania, with performance required between August 10-11, 2023. As a major supplier of medical materiel and services to the U.S. Department of Defense, the award supports...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $2,132.68 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 4561741968 Isotretinoin 40 mg capsules. Performance will take place in Conshohocken, Pennsylvania over one day in August 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense's medical supply chain. This delivery order was issued against the Medical-Surgical...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHK6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,958.75 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026. The pharmaceutical will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Logistics Agency's Medical Supply Chain, which provides critical pharmaceutical products to military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal contract awards demonstrating capability to fulfill diverse medical procurement requirements across multiple therapeutic domains. The award of Isotretinoin, an FDA-approved prescription medication, aligns with the company's established role as a primary vendor supplying specialized pharmaceuticals to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/9/25 |